Smith Jason Drew's Form 4 filing
UroGen Pharma Ltd. (URGN) · filed Feb 2, 2024
- Accession no.
- 0001437749-24-003018
- Filed
- Feb 2, 2024
- Trade date
- Jan 31, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $78.6K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001437749-24-003155 (Feb 5, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Jason DrewCIK 0001821479 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 | Ordinary Shares | MOption exerciseAcquired | +834 | –F1 | – | 19,241 | Direct | |
| Jan 31, 2024 | Ordinary Shares | SSaleDisposed | −417 | $15.74 | −$6,563.58 | 18,824 | Direct | |
| Jan 31, 2024 | Ordinary Shares | MOption exerciseAcquired | +2,500 | –F1 | – | 21,324 | Direct | |
| Jan 31, 2024 | Ordinary Shares | SSaleDisposed | −1,248 | $15.74 | −$19,643.52 | 20,076 | Direct | |
| Jan 31, 2024 | Ordinary Shares | MOption exerciseAcquired | +6,666 | –F1 | – | 26,742 | Direct | |
| Jan 31, 2024 | Ordinary Shares | SSaleDisposed | −3,328 | $15.74 | −$52,382.72 | 23,414 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 | Ordinary Shares | MOption exerciseDisposed | −834 | $0.00 | $0 | 0 | Direct | |
| Jan 31, 2024 | Ordinary Shares | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 2,500 | Direct | |
| Jan 31, 2024 | Ordinary Shares | MOption exerciseDisposed | −6,666 | $0.00 | $0 | 13,334 | Direct | |
| Jan 31, 2024 | Ordinary Shares | AGrant or awardAcquired | +16,500 | $0.00 | $0 | 16,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
Referenced by the price of 3 transactions in Table I.